The COVID-19 pandemic has fundamentally altered health priorities around the world. Across all sectors, organizations are engaging with digital solutions to tackle the spread of the virus and relying on data to make critical decisions around healthcare delivery and resource prioritization. In this webinar, panelists will discuss why we are seeing an increase in the use of digital during the COVID-19 pandemic, and how this extreme experience has awakened the world to the crucial infrastructure that needs to be in place in order to rapidly respond to future health emergencies.
Moderator: Bruno Villetelle
Head of Data and Digital Global Drug Development, Novartis
Bruno joined Novartis in April 2019 and leads the Data and Digital function for the company’s Global Drug Development (GDD) organization. He drives GDD’s data and digital vision, strategy and governance, and is focused on embedding data science and digital technologies to enhance asset development. Bruno has more than 30 years of experience spearheading digital and technology led innovation and new business model creation in the pharmaceutical, consumer health, and service industries. Prior to joining Novartis, he worked for Takeda Pharmaceutical Company Limited as the Chief Digital Officer.
Bruno has a Master of Science degree in Industrial Organization & Methodology and a Master of Science in Business Systems Management from the University of Lyon, France. He also has a Master of Engineering in Enterprise Information Systems from the Conservatoire des Arts et Métiers, France. In 2017, he was nominated one of the Top 40 healthcare transformers by MM&M (Medical, Marketing and Media).